We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNDX icon
126
Syndax Pharmaceuticals
SNDX
$1.84B
$37M 0.17%
1,696,040
+770,708
+83% +$16M
BMO icon
127
Bank of Montreal
BMO
$122B
$36.9M 0.17%
209,138
-34,884
-14% -$5.48M
ZS icon
128
Zscaler
ZS
$27.7B
$36.5M 0.16%
258,585
+4,997
+2% +$697K
TRV icon
129
Travelers Companies
TRV
$77B
$36.3M 0.16%
110,075
+9,176
+9% +$2.78M
RL icon
130
Ralph Lauren
RL
$20.9B
$36.1M 0.16%
89,927
-41,666
-32% -$15.5M
DELL icon
131
Dell
DELL
$339B
$35.7M 0.16%
82,932
+13,975
+20% +$4.04M
ADP icon
132
Automatic Data Processing
ADP
$110B
$35.6M 0.16%
159,282
-60,654
-28% -$13M
IONS icon
133
Ionis Pharmaceuticals
IONS
$9.65B
$35.3M 0.16%
445,019
-39,034
-8% -$2.94M
COHR icon
134
Coherent
COHR
$55.2B
$35.1M 0.16%
89,086
-49
-0.1% -$17.3K
NFLX icon
135
Netflix
NFLX
$326B
$34.7M 0.16%
486,564
-254,311
-34% -$22.4M
WST icon
136
West Pharmaceutical
WST
$23.9B
$34.6M 0.16%
96,349
+87,225
+956% +$26.7M
DHR icon
137
Danaher
DHR
$146B
$34.4M 0.16%
180,852
-95,099
-34% -$17.3M
TRMB icon
138
Trimble
TRMB
$13.9B
$34.2M 0.15%
669,169
-38,121
-5% -$2.25M
ZTS icon
139
Zoetis
ZTS
$31.3B
$34.1M 0.15%
474,935
+16,081
+4% +$1.51M
URI icon
140
United Rentals
URI
$62.9B
$34M 0.15%
29,998
+19,006
+173% +$18.1M
ORKA
141
Oruka Therapeutics
ORKA
$6.13B
$33.5M 0.15%
352,716
-58,290
-14% -$3.88M
CVS icon
142
CVS Health
CVS
$124B
$33.5M 0.15%
324,260
-61,542
-16% -$5.49M
RARE icon
143
Ultragenyx Pharmaceutical
RARE
$1.51B
$33.4M 0.15%
1,001,841
-94,341
-9% -$2.34M
CGON icon
144
CG Oncology
CGON
$6.62B
$33.3M 0.15%
469,170
-72,866
-13% -$4.76M
TFC icon
145
Truist Financial
TFC
$63.1B
$33.1M 0.15%
664,502
+528,776
+390% +$26M
CM icon
146
Canadian Imperial Bank of Commerce
CM
$107B
$32.9M 0.15%
285,895
-11,818
-4% -$1.3M
AWK icon
147
American Water Works
AWK
$28B
$32.2M 0.15%
245,162
-140,451
-36% -$18M
EBAY icon
148
eBay
EBAY
$46B
$31.6M 0.14%
282,680
+202,204
+251% +$21.6M
VRDN icon
149
Viridian Therapeutics
VRDN
$2.6B
$31.3M 0.14%
1,707,698
+995,959
+140% +$16M
CRNX
150
DELISTED
Crinetics Pharmaceuticals
CRNX
$30.6M 0.14%
819,032
-11,929
-1% -$443K
4 5
6
7 8

Similar funds

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.